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a b s t r a c t
The effects of feed solution pH and membrane orientation on water flux and the rejection of carbamaz-
epine and sulfamethoxazole were investigated using a bench scale forward osmosis (FO) system. Water
flux was pH-dependent in both membrane orientations. In addition, water flux increased while the spe-
cific reverse salt flux and hydrogen ion flux decreased with increasing feed solution pH. Water flux was
lower in the normal FO mode compared to that in the pressure retarded osmosis (PRO) mode because
osmotic pressure differential was reduced due to the internal concentration polarisation (ICP) phenom-
enon. The rejection of neutral carbamazepine was generally pH independent in both membrane orienta-
tions. The rejection of carbamazepine in the PRO mode was lower than that in the FO mode due to the
higher concentration gradient caused by concentrative ICP in porous supporting layer. Steric hindrance
was probably the main separation mechanism for the neutral carbamazepine in the FO process. On the
other hand, the rejection of sulfamethoxazole was significantly affected by the feed solution pH in both
membrane orientations. Variation in the rejection sulfamethoxazole could be attributed to the electro-
static repulsion between the negatively charged FO membrane surface and varying effective charge of
the sulfamethoxazole molecule.
Crown Copyright  2012 Published by Elsevier B.V. All rights reserved.
1. Introduction
The last two decades have seen the shortage of drinking water
supply further exacerbated due to population growth, irregular
weather patterns as a result of climate change, and environmental
contamination [1,2]. At the same time, trace organic contaminants
of anthropogenic origin have also emerged. These trace organic
contaminants have been frequently detected at trace level ranging
from a few nanogram per litre (ng/L) to several microgram per litre
(lg/L) in sewage, effluent from sewage treatment plants, water
bodies, and in some cases, even drinking water [3–6]. Some of
these contaminants are pharmaceutically active or can potentially
induce a range of adverse endocrine disrupting effects on verte-
brates at environmentally relevant concentrations (i.e., several
ng/L). Not surprisingly, many dedicated studies have been focused
on the use of advanced water treatment technologies for effective
removal these trace organic contaminants, thus allowing for the
utilisation of non-conventional water sources such as treated efflu-
ent. Around the world, a number of water reclamation facilities
have been built to provide a supplementary source of water supply
[7,8]. In many countries including the USA, Singapore, and several
European states, water recycling has been shown to be a successful
strategy to ensure the replenishment of catchment or reservoir for
potable water supply and reduce dependency on sources vulnera-
ble to climate change [1,8,9]. Examples of advanced treatment
technologies widely used in water recycling applications to ensure
sufficient removal of trace organic contaminants include nanofil-
tration or reverse osmosis, and ultraviolet radiation [8,10].
Although these advanced treatment processes demonstrate effi-
cient removal of a wide range of trace organic contaminants from
impaired water resources, they can be energy intensive. As a result,
several new treatment technologies have been proposed and
investigated in recent years.
Forward osmosis (FO) is one such emerging water treatment
technology. FO utilises an osmotic pressure differential to drive
the permeation of clean water across the membrane into the draw
solution [11]. FO is highly attractive for water treatment due to its
low fouling propensity [12], simple configuration, and low energy
consumption [13,14]. Consequently, a number of investigations
have focused on the use of FO in wastewater treatment. The effec-
tiveness of FO has been demonstrated by the treatment of landfill
leachate [15], anaerobic digester concentrate [16], activated sludge
solution [17,18], and domestic wastewater [19]. In most cases, FO
is used as an advanced pre-treatment technique in conjunction
with a draw solution recovery process, such as reverse osmosis
(RO) and membrane distillation (MD). In a recent study, Cath
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et al. [20] proposed such a hybrid FO–RO system to combine
wastewater reclamation and seawater desalination. In this hybrid
system, treated effluent with low osmotic pressure (low salinity)
is first treated by an FO membrane and clean water is drawn into
a seawater draw solution. The diluted draw solution is subse-
quently desalinated by RO to produce fresh water suitable for ben-
eficial uses. In another study, Wang et al. [21] demonstrated a
hybrid FO–MD system to treat highly viscous protein solution
where FO is employed for dewatering protein solutions while MD
is used for draw solution recovery. These hybrid systems are capa-
ble of providing a dual-barrier treatment against trace organic con-
taminants and largely reducing the treatment burden of
downstream processes. In addition, because FO has very low foul-
ing propensity, these hybrid systems can be used to treat feed
water of low quality. Hancock et al. [22] recently conducted a life
cycle assessment exercise to compare the environmental impact
of the FO–RO dual-barrier concept and RO technology for seawater
desalination application. They reported that, if the full technical
potential of FO technology can be realised, the environment impact
of an FO–RO hybrid system is 25% less than that of the current
state-of-the-art RO process [22]. It is noteworthy that a draw solu-
tion recovery process is not required in all cases. When the draw
solute can add value to the extracted water, the diluted draw solu-
tion can be directly consumed without any further treatment [23].
Examples of these applications include several FO water purifica-
tion products (such as X-pack, Life Pack, Expedition, and Hydro-
Well) that are commercially available from Hydration Technology
Innovations (www.htiwater.com) and even the extraction of water
from urine for direct consumption by astronauts during their space
mission [24]. In these applications, it is essential that trace organic
contaminants are effectively removed by the FO process.
Little is known about the removal behaviours of trace organic
contaminants during the FO process. Cartinella et al. [25] demon-
strated that FO can completely remove the steroid hormones es-
trone and estradiol. Cath et al. [20] investigated the removal of
diclofenac, gemfibrozil, naproxen and salicylic acid by an FO mem-
brane and reported rejection values of 99%, 80%, 90% and 72%,
respectively. Similar rejection of 13 trace organic contaminants
by FO membrane was observed as well [26]. Hancock et al. [27] re-
vealed significant variation in the rejection of trace organic con-
taminants by the FO process in the range from 40% (tris-(2-
carboxyethyl)-phosphine (TCEP)) to more than 95% (sulfamethox-
azole) when they examined the separation of 30 compounds using
a bench scale FO system. Given the similarity between the molec-
ular weight of TCEP (250 g/mol) and sulfamethoxazole (253 g/
mol), the underlying reasons for their significantly different rejec-
tion behaviours remain largely unknown. In addition, because
mass transfer in the FO process is driven exclusively by a chemical
concentration gradient, the transport mechanisms of the FO and
pressure driven filtration processes such as NF and RO may not
be the same. In fact, Xie et al. [28] has demonstrated that at the
same permeate flux, rejection of some hydrophobic trace organics
under the FO mode was higher than that under the RO mode. The
authors attributed this observation to the retarded forward diffu-
sion phenomenon that could occur in the FO process at high draw
solute flux.
The FO membrane can be operated in two different configura-
tions, namely the normal FO mode and pressure retarded osmosis
(PRO) mode. The former refers to a configuration in which the ac-
tive layer of the FO membrane is placed against the feed solution,
while the latter refers to a configuration in which the active layer
of the FO membrane is placed against the draw solution. Jin et al.
[29] through a modelling study showed that the boron flux in
the PRO mode was higher than that in the FO mode. Mi and Elime-
lech [30] experimentally demonstrated that membrane fouling
was more severe in the PRO mode than that in the FO mode. Tang
et al. [31] have subsequently reported similar observations. How-
ever, there remains a lack of systematic and mechanistic under-
standing of the rejection of trace organic contaminants by FO in
the two membrane orientations. Such understanding is essential
for further development of the FO technology, especially when it
is used to purify water contaminated with trace organics.
In this study, we examined the water flux behaviour and rejec-
tion of two PhACs – namely sulfamethoxazole and carbamazepine
– by an FO membrane. The water flux, reverse salt flux, and hydro-
gen ion flux were systematically related to the surface charge and
hydrophobicity of the membrane at different feed solution pH and
two membrane orientations. Experimental results were analysed
to elucidate the effects of solution pH and membrane orientation
on water flux and PhACs rejection, thus providing further insight
into the rejection mechanisms of trace organic contaminants by
FO membrane.
2. Materials and methods
2.1. FO membrane
An asymmetric FO membrane acquired from Hydration Tech-
nology Innovations (HTI, Albany, OR) was used in this investiga-
tion. According to the manufacturer, the operational pH range of
this membrane is from pH 3.5 to 7.5. This membrane exhibited
comparably lower water permeability and higher salt rejection
than a typical commercial NF membrane. Although the actual com-
position of the membrane is proprietary information, it has been
suggested that the membrane has a dense cellulose-based active
layer embedded in polyester mesh providing mechanical support.
A detailed description of the membrane is provided elsewhere [11].
2.2. Laboratory scale FO system
FO experiments were conducted using a closed-loop bench-
scale flat plate FO membrane system (Supplementary Data,
Fig. S1). The membrane cell was made of acrylic plastic. The dimen-
sions of the channels were 13 cm long, 9.5 cm wide, and 0.2 cm
deep. The total effective membrane area for mass transfer was
123.5 cm2.
Two variable speed gear pumps (Micropump, Vancouver, WA)
were used to circulate the feed and draw solutions. Flow rates of
the feed and draw solution flow were monitored using two rotam-
eters and kept constant at 1 L/min (corresponding to a cross flow
velocity of 9 cm/s). The draw solution reservoir was placed on a
digital balance (Mettler Toledo Inc., Hightstown, NJ) and weight
changes were recorded by a computer to calculate the permeate
flux. The conductivity of the draw solution was continuously mea-
sured using a cell constant of K = 1 cm1 conductivity probe (Cole-
Parmer, Vernon Hills, Illinois). To maintain constant draw solution
concentration, a peristaltic pump was regulated by a conductivity
controller to intermittently dose a small volume of a high concen-
tration draw solution (6 M) into the draw solution reservoir (con-
trol accuracy ±0.1 mS/cm). The concentrated draw solution
makeup reservoir was also placed on the same digital balance.
The transfer of liquid between the two reservoirs did not interfere
with the measurement of permeate flux and the system could be
operated with a constant osmotic pressure.
2.3. Experimental protocol
The feed was prepared by spiking carbamazepine and sulfa-
methoxazole (Sigma–Aldrich, Saint Louis, MO) into a background
electrolyte solution (20 mM NaCl and 1 mM NaHCO3) to generate
a concentration of 250 lg/L. These background electrolytes were
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selected to simulate the typical composition in the treated second-
ary effluent and to maintain the constant pH of the feed solution
[32,33]. Either HCl (1 M) or NaOH (1 M) was used to adjust the
pH value of the feed solution. Analytical grade NaCl (Fisher
Scientific, Pittsburgh, PA) was used to prepare the draw solution
in Milli-Q water. The volumes of the feed solution and draw solu-
tion were 4 and 1 L, respectively. Temperatures of the feed and
draw solutions were kept constant at 23 ± 0.1 C using a tempera-
ture control unit (Thermo Fisher Scientific, Waltham, MA) in all
experiments. Both FO and PRO mode experiments were conducted.
In the FO mode experiments, the active layer of the FO membrane
was placed against the feed solution, and in the PRO mode exper-
iments, the active layer of the FO membrane was placed against the
draw solution. A new FO membrane sample was used for each
experiment. Approximately 1 mL of samples from both the feed
tank and draw solution tank were taken at specific intervals for
HPLC analysis.
2.4. Contact angle measurement
Contact angle measurements were conducted using a Rame-
Hart Goniometer (Model 250, Rame-Hart, Netcong, NJ) and em-
ployed a standard sessile drop method. FO membrane samples
were submerged into a pH-adjusted electrolyte background solu-
tion (20 mM NaCl and 1 mM NaHCO3) ranging from pH 3.5 to 7.5
for 10 h. After removing excess liquid, the membrane samples
were fixed onto a glass slide using double-sided adhesive tape
and then dried in a desiccator for at least 24 h prior to contact an-
gle measurements. pH-adjusted Milli-Q water was used as the ref-
erence solvent for the corresponding pH-adjusted membrane
sample. Ten water droplets were used on each membrane sample
and contact angles on both sides of the droplet were analysed.
2.5. Zeta potential measurement
The zeta potential of the membrane surface was determined
using a SurPASS electrokinetic analyser (Anton Paar GmbH, Graz,
Austria). The zeta potential of each membrane surface was calcu-
lated from the measured streaming potential using the Fairbroth-
er-Mastin approach. All streaming potential measurements were
conducted in a background electrolyte solution containing
10 mM KCl. Hydrochloric acid and potassium hydroxide were used
to adjust pH by means of automatic titration. The test solution was
used to flush the cell thoroughly prior to the pH adjustment for
each measurement. All streaming potential measurements were
performed at room temperature (approximately 22 C), which
was monitored by the temperature probe of the instrument.
2.6. Representative PhACs
Two pharmaceuticals, namely sulfamethoxazole and carbamaz-
epine, were selected for this study. Their key physicochemical
properties together with molecular structures are presented in
Table 1. Sulfamethoxazole and carbamazepine are frequently de-
tected in secondary treated effluent, sewage affected water bodies,
and recycled water for non-potable purposes (see for example:
[34,35]). They represent two different drug categories. Sulfameth-
oxazole is a frequently used antibiotic while carbamazepine is a
widely used anti-epileptic drug. These compounds were purchased
from Sigma–Aldrich (St. Louis, MO) and their reported purities
were 99% or higher. The pharmaceuticals were first dissolved in
pure methanol to make up stock solutions of 1 g/L. The stock solu-
tions were stored at 18 C and were used within one month.
2.7. Analytical methods
A Shimadzu HPLC system (Shimadzu, Kyoto, Japan) equipped
with a Supelco Drug Discovery C-18 column (with diameter,
length, and pore size of 4.6 mm, 300 mm, and 5 lm, respectively)
and a UV–vis detector was used to measure the concentrations of
the sulfamethoxazole and carbamazepine in the feed and draw
solutions. The detection wavelength was 280 nm and sample injec-
tion volume was 50 lL [36]. The mobile phase composed of aceto-
nitrile and Milli-Q grade deionised water buffered with 25 mM
KH2PO4. Two eluents, namely, eluent A (80% acetonitrile + 20% buf-
fer, v/v) and eluent B (20% acetonitrile + 80% buffer, v/v) were
delivered at 1.0 mL/min through the column in time-dependent
gradient proportions for 20 min. The detailed eluent gradient time
program is provided in the Supplementary Data, Table S1. Calibra-
tion generally yielded standard curves with coefficients of determi-
nation (R2) greater than 0.99 within the range of experimental
concentrations used. The analysis was carried out immediately
upon the conclusion of each experiment. A sample injection vol-
ume of 50 lL was used considering the salt tolerance of C18 col-
umn. The quantification limit for all the analytes under
investigation using these conditions was approximately 10 lg/L.
Conductivity and pH of the feed and draw solutions were mea-
sured using an Orion 4-Star Plus pH/conductivity metre (Thermo
Fisher Scientific, Waltham, MA).
2.8. Rejection calculation
In a typical FO process, the permeate concentration of target
solute is diluted by the draw solution. Therefore, the apparent con-
centration of the target solute in the draw solution overestimates
the actual rejection performance. To evaluate the real performance
of the FO process, the actual (corrected) concentration of the target






where Vw(t) is the permeate volume of water to the draw solution at
time t, Vds(t-1) is the volume of draw solution at time (t-1), Vds(t) is
the volume of draw solution at time t, Cds(t) is the measured concen-
tration of target solute in the draw solution at time t, and Cds(t-1) is
the measured concentration of target solute in the draw solution at
time (t-1). Subsequently, the solute rejection in the FO process is







where Cf(t) is the concentration of the target solute in the feed at t
time.
3. Results and discussion
3.1. Flux behaviour
3.1.1. Permeate water flux
The asymmetric membrane can be operated in two different
orientations, namely FO and PRO modes. The water flux obtained
from the PRO mode was considerably higher than that in the FO
mode (Fig. 1). This difference in water flux is due to the internal
concentration polarisation (ICP) phenomenon which has been de-
scribed in detail in several previous studies [37,38]. ICP occurs
when the solute concentration within the membrane supporting
layer differs from that of the bulk solution. In the FO mode, the
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draw solution inside the porous supporting layer becomes diluted
as water permeates from the feed through the active layer into the
protective confines of the membrane supporting structure. In the
PRO mode, the feed solute is concentrated within the porous sup-
porting layer, thus reducing the overall osmotic gradient across the
membrane. McCutcheon and Elimelech [38] referred to these two
phenomena as dilutive and concentrative ICP, respectively. Be-
cause the osmotic pressure of the feed solution was much smaller
than that of the draw solution, the dilutive ICP in the FO mode is
more pronounced than concentrative ICP in the PRO mode, which
substantially reduces the effective osmotic driving force for water
flux. While the ICP phenomenon may not impact the osmotic pres-
sure at the feed side in the PRO mode, it can lead to the build-up of
PhACs within the supporting layer of the membrane at the feed
side, thus influencing the rejection of the PhACs. Effects of the
ICP phenomenon on the rejection of sulfamethoxazole and car-
bamazepine will be discussed in detail in section 3.2.
Water flux was a function of the feed solution pH in both orien-
tations (Fig. 1). The water flux increased by 27.6% and 7.5% in the
FO and PRO modes, respectively, as the feed solution pH increased
from 3.5 to 7.5. This behaviour may be attributed to conforma-
tional changes of the cross-linked membrane polymer structure
and changes in the membrane hydrophobicity as a function of
the solution pH. These two possible mechanisms can be elucidated
by membrane surface charge characteristics, especially the zeta
potential profiles of the active layer (Fig. 1a) and supporting layer
(Fig. 1b) as well as the hydrophobicity (Table 2) of the FO
membrane. It is hypothesised that the electrostatic repulsion be-
tween ionisable functional groups of the membrane polymeric ma-
trix increases as the solution pH increase, thereby leading to an
increased average pore size and higher permeate flux. Indeed, the
zeta potential of both the active layer and the supporting layer
became more negatively charged with increasing feed solution
pH. The results reported in Fig. 1 are also in good agreement with
the pH-dependent water flux response in some nanofiltration
processes [39,40]. It is also noted that the FO membrane surface
becomes more hydrophilic through dissociation of carboxyl
functional groups (COO) of the active layer as the solution pH
increased (Table 2). A more hydrophilic membrane could favour
water transport. In fact, this hypothesis is consistent with the
correlation between hydrophobicity of FO membrane and water
flux observed by McCutcheon and Elimelech [41].
3.1.2. Reverse salt flux and hydrogen ion flux
The specific reverse salt flux (Js/Jw) is a quantitative indicator for
bi-directional diffusion in the FO process. Higher specific reverse
salt flux reflects a decrease in the selectivity of the membrane
Table 1
Key physicochemical properties of PhACs used in this study.
Pharmaceutical Carbamazepine Sulfamethoxazole
Structure
Molecular weight (Da) 236.3 253.3
pKaa 9.73 1.7, 5.8
Log Kowa 2.45 0.89
Dipole moment (Debye)b 3.6 5.4
Stokes radius (nm) 0.37 0.38
Molecular length (nm)b 0.891 1.031
Molecular width (nm)b 0.529 0.587
Molecular depth (nm)b 0.507 0.526
a From the SciFinder Scholar (ACS) database.
b Molecular dimension and the dipole moment were calculated using Molecular
Modelling Pro Version 6.3.3 (Chem SW Inc.).
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Fig. 1. The water flux as a function of feed pH in FO and PRO modes. Experimental conditions were: 1 M NaCl as draw solution, the cross flow rate was 1 L/min for both sides,
and the cross flow velocity was 9 cm/s. The temperature of both sides was kept at 23 ± 0.1 C. Zeta potential of active and supporting layer of the HTI FO membrane was
measured with background electrolyte of 1 mM KCl. The error bar represents the standard deviation from duplicate experiments.
Table 2
Contact angle of the active and supporting layers of the FO membrane at different pH
values (mean ± standard deviation of ten repeated measurements).
pH Active layer () Supporting layer ()
3.5 70.9 ± 3.1 79.7 ± 1.0
4.5 66.7 ± 3.6 75.0 ± 3.2
5.5 64.8 ± 2.9 70.8 ± 3.2
6.5 62.8 ± 3.9 71.1 ± 1.8
7.5 60.2 ± 3.4 69.7 ± 3.4
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and the lower efficiency of the process [42]. In both the FO and PRO
modes, the specific reverse salt flux decreased with increasing feed
solution pH (Fig. 2). This implies that better selectivity and effi-
ciency are expected with a basic feed solution rather than that with
an acidic one. This decrease in the specific reverse salt flux is
mostly driven by the increase in water flux. The water flux
increases significantly at higher pH whilst the salt flux is sup-
pressed by the more negatively charged FO membrane.
The pH of the feed solution consistently increased during the
course of each experiment (Fig. 3). Due to the feed volume reduc-
tion during the FO process, the measured changes in the feed pH
during the experiment may not reflect the transport of hydrogen
ion. Thus, the molar flux of hydrogen ion out of the feed solution
is used to describe the hydrogen ion transport. Similar feed pH var-
iation was also observed by Hancock et al. [42] and Phuntsho et al.
[43]. This pH variation can be explained by charge neutrality and
concentration gradient driven diffusion. Hydrogen ion diffuses
through the FO membrane to maintain feed solution electroneu-
trality when sodium permeates into the feed side. Therefore,
higher specific reverse salt flux in the FO mode (Fig. 2) leads to
the higher hydrogen ion flux. In addition, according to Fick’s law,
the hydrogen ion flux is directly proportional to the difference in
ion concentrations across the membrane [44]. The hydrogen ion
concentration gradient decreases with increasing feed pH, and thus
a decreased hydrogen ion flux is expected as observed in this
study.
3.2. Rejection of PhACs
3.2.1. General behaviour
The feed solution pH and membrane orientation play key roles
in the rejection of carbamazepine and sulfamethoxazole. The rejec-
tion profile of carbamazepine is relatively pH-independent, while
that of sulfamethoxazole is strongly pH-dependent within the pH
range of this study. The stable rejection of carbamazepine
(Fig. 4a) can be ascribed to its neutral form in the pH range
investigated here. In contrast, feed solution pH had a considerable
effect on the rejection of sulfamethoxazole (Fig. 4b). At near neu-
tral pH values (pH 6.5 and 7.5), the rejection of sulfamethoxazole
was above 90 % and constant throughout the experiment.
However, at acidic pH values (i.e., pH 3.5, 4.5, and 5.5), the rejec-
tion of sulfamethoxazole was low and decreased gradually over
the first few hours of experiment. This pH-dependence behaviour
resulted from the speciation of sulfamethoxazole (pKa of
sulfamethoxazole = 5.8), from a neutral species at high pH to a
negatively charged one at lower pH [45,46]. The initial and gradual
decrease in sulfamethoxazole rejection at low pH observed in Fig. 4
may be attributed to the hydrogen ion flux from the feed to the
draw solution (Fig. 3) which may result in a higher localised pH
immediately at the membrane surface. Further investigation is
required to fully substantiate this phenomenon.
Membrane orientation had a direct impact on the rejection pro-
files of the two compounds. The rejection of carbamazepine was
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Fig. 2. Permeate of hydrogen ion flux from the feed as a function of initial feed pH in FO and PRO modes. Hydrogen ion flux was calculated based on the pH change of the feed
at the end of a 10-hour experiment. The draw solution (1 M NaCl) pH was 6.25.
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approximately 90% in the FO mode (Fig. 4a), while a rejection of
only 70% was obtained in the PRO mode (Fig. 5a). The rejection
behaviour of sulfamethoxazole was also notably different in the
two membrane orientations. At unfavourable acidic pH values,
more than 50% of sulfamethoxazole was removed in the FO mode
(Fig. 4b), but only 20% rejection of sulfamethoxazole was found for
the PRO mode (Fig. 5b).
3.2.2. Effect of solution pH
The feed pH appears to be a major parameter governing the
rejection of sulfamethoxazole in the FO process. Results presented
in Fig. 6a are consistent with the behaviour of sulfamethoxazole
during nanofiltration processes [45] and may be attributed to a
combination of the speciation of the compound, membrane surface
charge, and feed solution pH. Carbamazepine, with pKa value of
9.73, is a neutral compound in the investigated pH range of 3.5
to 7.5. Thus, steric hindrance (and not electrostatic interaction) is
the dominant rejection mechanism for carbamazepine. This
hypothesis is supported by the constant rejection value of carbam-
azepine of approximately 90% regardless of the feed solution pH. It
is noteworthy that rejection of the neutral sulfamethoxazole (at pH
3.5 and 4.5) is lower than carbamazepine (Figs. 4 and 5) while the
molecular weight of sulfamethoxazole is comparable to that of car-
bamazepine (Table 1). This different rejection behaviour may be
due to the dipole moment and molecular shape of these two
compounds. In the absence of electrostatic interaction, sulfameth-
oxazole facilitated with a high dipole-fixed charge interaction is
more likely to be attracted to the membrane pores [47]. In addi-
tion, sulfamethoxazole is cylindrical in shape with large molecular
length and small molecular width and depth (Table 1). Nghiem
et al. [46] have also reported lower rejection of the neutral
sulfamethoxazole compared to that of carbamazepine by an NF
filtration process.
On the other hand, sulfamethoxazole can dissociate from a neu-
tral species to a negatively charged anion as the feed pH becomes
increasingly more acidic below its pKa value of 5.8. The active layer
of the membrane becomes more negatively charged with increas-
ing feed pH [30]. Hence, the rejection mechanism is controlled
by both steric hindrance and electrostatic repulsion between the
negatively charged active layer of FO membrane and anionic sulfa-
methoxazole. These interactions result in a near complete rejection
of sulfamethoxazole at pH values beyond its pKa. It is interesting to
note that the sigmoidal rejection curve of sulfamethoxazole as a
function of feed pH resembles the shape of its speciation
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Fig. 3. Water, reverse salt (NaCl) and specific reverse salt fluxes in the FO and PRO modes at different feed pH values. The experimental conditions were described as in Fig. 1.



























































Fig. 4. The rejection of (a) carbamazepine, and (b) sulfamethoxazole as a function of
time at different feed pH in FO mode (concentration of carbamazepine and
sulfamethoxazole = 250 lg/L in the feed, the background electrolyte contained
20 mM NaCl and 1 mM NaHCO3, draw solution = 1 M NaCl; cross flow velocity on
either sides of the membrane = 9 cm/s; feed and draw solution tempera-
ture = 23 ± 0.1 C). The error bar represents the standard deviation from duplicate
experiments.
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nificant governing mechanism in the separation of sulfamethoxa-
zole by FO membrane.
3.2.3. Effect of membrane orientation
Membrane orientation can exert some impact on the rejection
of carbamazepine and sulfamethoxazole during the FO process.
For the neutral compound carbamazepine, the rejection in the FO
mode was 20% higher than that in the PRO mode (Fig. 6). The dif-
ferent rejection behaviour of carbamazepine in the FO and PRO
modes is attributed to the ICP effect. Because the ICP phenomenon
may not significantly impact the osmotic pressure gradient in the
PRO mode, the effective mass transfer driving force in the PRO
mode is higher than that in the FO mode. In addition, in the PRO
mode, carbamazepine is subjected to the concentrative ICP within
the porous supporting layer of the membrane [29] leading to a
higher concentration gradient across the dense active layer of the
membrane. Therefore, the ICP phenomenon can negatively affect
the rejection of carbamazepine in a similar fashion to that caused
by the normal concentration polarisation phenomenon. At pH 3.5
and 4.5, the rejection of sulfamethoxazole in the PRO mode was
lower than that in the FO mode, but with the increase of feed solu-
tion pH, the rejection of sulfamethoxazole increased with insignif-
icant difference in sulfamethoxazole rejection between the two
membrane orientations. It is noted that the supporting layer of
the membrane was more negatively charged than the active layer
when the pH was above 5.5 (Fig. 1). Thus, the rejection of sulfa-
methoxazole was enhanced by electrostatic repulsion between
the negatively charged supporting layer and the negatively
charged compound. This enhanced electrostatic repulsion between
the ionised sulfamethoxazole and the FO membrane could lead to
the deformed sigmoidal rejection curve as observed in Fig. 6b. This
observed enhanced rejection performance is also consistent with
the decreased specific salt flux discussed in section 3.1.2.
4. Conclusion
In this study, we investigated the effects of membrane orienta-
tion and feed solution pH on permeate flux and rejection of car-
bamazepine and sulfamethoxazole by an FO membrane. The
following conclusions could be drawn: (i) water flux was pH-
dependent in both membrane orientations. An increase in water
flux was observed with the increase of the feed solution pH, and
the specific reverse salt flux and hydrogen ion flux were hindered
in the basic pH range. These observations agreed well with the zeta
potential measurements of the FO membrane; (ii) the feed solution
pH induced different rejection behaviour for carbamazepine and
sulfamethoxazole. Rejection of the neutral carbamazepine com-
pound was independent of pH, while rejection of sulfamethoxazole
was significantly affected by pH as the speciation of sulfamethox-
































































Fig. 5. The rejection of (a) carbamazepine, and (b) sulfamethoxazole as a function of
time at different feed pH in PRO mode (experimental conditions were as per Fig. 4).
The error bar represents the standard deviation from duplicate experiments.





























































Fig. 6. Rejection sulfamethoxazole and carbamazepine in (a) FO mode, (b) PRO
mode as a function of feed pH and (c) the speciation of sulfamethoxazole as a
function of pH. The data points represented the rejection at the end of 10-h
experiments (experimental conditions were as per Fig. 4).
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azole varied with pH; (iii) membrane orientation played an impor-
tant role in both water flux and PhACs rejection behaviour. Due to
concentrative and dilutive ICP effects, water flux was higher in the
PRO mode than that with the FO mode. In the PRO mode, concen-
trative ICP in the porous supporting layer of the FO membrane re-
sulted in a lower PhACs rejection value than that in the FO mode.
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